--- a
+++ b/clusters/9knumclustersv2/clust_1575.txt
@@ -0,0 +1,30 @@
+Corticosteroid dose must be stable or decreasing for at least  days prior to the baseline MRI scan
+Corticosteroids: If used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Patients receiving corticosteroids must have been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Corticosteroids: Patients receiving corticosteroids must have been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Concomitant medications\r\n* Corticosteroids: Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid \r\n* Investigational drugs: Patients who are currently receiving another investigational drug are not eligible\r\n* Anti-cancer agents: Patients who are currently receiving other anti-cancer agents are not eligible
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Patients requiring corticosteroids who have not been on a stable or decreasing dose of corticosteroid for the  days prior to enrollment are not eligible; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Patients requiring corticosteroids who have not been on a stable or decreasing dose of corticosteroid for the  days prior to enrollment are not eligible
+Subjects receiving corticosteroids must be on a stable or decreasing dose of corticosteroid for the prior  days
+Patients requiring corticosteroids who have not been on a stable or decreasing dose of corticosteroid for the  days prior to enrollment are not eligible.
+Patients receiving systemic corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of systemic corticosteroid; Note: patients who are using topical or inhaled corticosteroids are eligible
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible
+Corticosteroid dose must be stable or decreasing for at least  days prior to the baseline MRI scan.
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Corticosteroid dose must be stable or decreasing for at least  days prior to the baseline CT or MRI scan
+Increasing corticosteroid dose in  days prior to administration of first dose of study drug. Symptomatic patients who have stable or decreasing corticosteroid use in the past  days may be included
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible.
+Patients requiring escalation of the corticosteroid dose will be excluded, but patients receiving a stable or decreasing dose for at least one week will be eligible
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible; if used to modify immune adverse events related to prior therapy, >=  days must have elapsed since last dose of corticosteroid
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment are not eligible
+Patients receiving corticosteroids who have not been on a stable or decreasing dose of corticosteroid for the prior  days are not eligible
+Corticosteroids: If used to modify immune adverse events related to prior therapy, ? days must have elapsed since last dose of corticosteroid. Participants receiving corticosteroids, who have not been on a stable or decreasing dose of corticosteroid for at least  days prior to enrollment, are not eligible
+Patients requiring corticosteroids who have not been on a stable or decreasing dose of corticosteroid for the prior  days
+At least  weeks post-craniotomy ( days for stereotactic biopsy), within  days prior to the start of SL-, and on a corticosteroid dosage that has been stable or decreasing for at least  days.
+Stable dose of corticosteroid >=  days prior to registration